Company intelligence / Profile preview

MagBio Genomics

Gaithersburg, Maryland, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

MagBio Genomics is a provider of magnetic bead-based reagents and kits for nucleic acid isolation, collection, stabilization, and preparation; their MagXtract Collection Tube received FDA 510(k) and CE Mark for COVID-19 sample transport, offering guanidine-free, room temperature stabilization of RNA for molecular diagnostics and NGS workflows.

Industry: Consumable Medical Devices

Partnerships

Mawi DNA Technologies (for automated RNA purification on iSWAB-RNA v2 platform using Thermofisher KingFisher Flex)

Beyond the preview

Go deeper on MagBio Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MagBio Genomics.

Explore the full profile